Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesThyroid Storm After Intensity-Modulated Radiation Therapy: A Case Report and Discussion
The Oncologist, 04/02/09
Diaz R et al. - A 43-year-old man with locally advanced squamous cell carcinoma of the base of tongue was treated with induction chemotherapy followed by intensity-modulated radiation therapy (IMRT). Within 20 days post-treatment, the patient developed clinical symptoms highly suggestive of hyperthyroidism. Two and one half months after completion of therapy, the patient developed severe thyrotoxicosis, which, in retrospect, appears to have met the criteria for thyroid storm.
Related Articles
Hormone Therapy Can Help Some with Prostate Cancer
MedLinePlus, 11/04/09
Relevance Score: 69%
Systematic Review: Charged-Particle Radiation Therapy for Cancer
Annals of Internal Medicine, 10/20/09
Relevance Score: 69%
Is Radiation Therapy for Keloids Acceptable? The Risk of Radiation-Induced Carcinogenesis
Plastic and Reconstructive Surgery, 10/12/09
Relevance Score: 69%
Radiation therapy for early breast cancer
Clinical and Translational Oncology, 10/07/09
Relevance Score: 69%
Shorter Radiation Course Stops Cancer Growth In High-risk Prostate Cancer Patients
ScienceDaily, 11/12/09
Relevance Score: 68%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
Experimental and Clinical Endocrinology & Diabetes, 12/19/09
Fas Ligand (FasL, Apo-1L/CD95L) Expression and Clinical Outcome in Papillary Microcarcinoma and Papillary Thyroid Carcinomas with Diameter Smaller than 1.5 Centimeters
Experimental and Clinical Endocrinology & Diabetes, 12/19/09
Metastatic signet ring cell carcinoma presenting as a thyroid nodule: Report of a case with fine-needle aspiration cytology
Diagnostic Cytopathology, 12/17/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Comparative proteomic profiling identified sorcin being associated with gemcitabine resistance in non-small cell lung cancer
Medical Oncology, 12/17/09
Anti-tumor activity and mechanisms of a novel vascular disrupting agent, (Z)-3,4?,5-trimethoxylstilbene-3?-O-phosphate disodium (M410)
Investigational New Drugs, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor